Characteristics of Patients With Opioid Use Disorder Associated With Performing Overdose Reversals in the Community: An Opioid Treatment Program Analysis

被引:16
|
作者
Katzman, Joanna G. [1 ,2 ,3 ]
Greenberg, Nina H. [4 ]
Takeda, Mikiko Y. [5 ]
Balasch, Monica Moya [1 ]
机构
[1] Univ New Mexico, Dept Neurosurg, Sch Med, MSC 10-5615, Albuquerque, NM 87131 USA
[2] Univ New Mexico, Dept Psychiat, Albuquerque, NM 87131 USA
[3] Univ New Mexico, Coll Nursing, MSC 10-5615, Albuquerque, NM 87131 USA
[4] Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA
[5] Univ New Mexico, Dept Pharm Practice & Adm Serv, Coll Pharm, Albuquerque, NM 87131 USA
关键词
characteristics; harm reduction; naloxone; opioid; overdose; INJECTION-DRUG USERS; HEROIN OVERDOSE; NALOXONE;
D O I
10.1097/ADM.0000000000000461
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Objective: The primary outcome of this study is to identify characteristics of study participants in a large opioid treatment program (OTP) for opioid use disorder (OUD) who used take-home naloxone to perform 1 or more opioid overdose (OD) reversal(s) in the community. Methods: This 6-month prospective cohort study provided take-home naloxone and opioid OD education for 287 study participants with OUD. Characteristics associated with use of the take-home naloxone were determined from among 16 variables using multivariable logistic regression. Results: The study participants who had greater odds of using the take-home naloxone to perform OD reversals, compared to those who did not use the take-home naloxone, (a) received emergency room care themselves for OD (OR = 4.89, 95% CI 1.54-15.52, P = 0.007), (b) previously witnessed someone else OD (OR = 5.67, 95% CI 1.24-25.87, P = 0.025), (c) tested positive for 2 or more illicit substances at their 6-month urine analysis (OR = 5.26, 95% CI 1.58-17.54, P = 0.007) or were missing their 6-month urine analysis (OR = 3.46, 95% CI 1.42-8.43, P = 0.006). In addition, they had greater odds of being (d) less than 30 years old (OR = 2.80, 95% CI 1.02-7.66, P = 0.045), and (e) Hispanic (OR = 3.98, 95% CI 1.41-11.21, P = 0.009). Conclusions: This study prospectively identified several characteristics of patients enrolled in an OTP with increased odds of using take-home naloxone in their social networks. Future harm reduction efforts may benefit by using targeted characteristics to identify those most likely to use naloxone in their communities.
引用
收藏
页码:131 / 138
页数:8
相关论文
共 50 条
  • [1] Association of Take-Home Naloxone and Opioid Overdose Reversals Performed by Patients in an Opioid Treatment Program
    Katzman, Joanna G.
    Takeda, Mikiko Y.
    Greenberg, Nina
    Moya Balasch, Monica
    Alchbli, Amal
    Katzman, William G.
    Salvador, Julie G.
    Bhatt, Snehal R.
    JAMA NETWORK OPEN, 2020, 3 (02)
  • [2] Opioid overdose and naloxone education in a substance use disorder treatment program
    Lott, David C.
    Rhodes, Jonathan
    AMERICAN JOURNAL ON ADDICTIONS, 2016, 25 (03): : 221 - 226
  • [3] Opioid Use Disorder Education for Students and the Future of Opioid Overdose Treatment
    Balapal, Neha
    Ankem, Amala
    Shyamsundar, Saishravan
    He, Shuhan
    JMIR MEDICAL EDUCATION, 2022, 8 (03):
  • [4] Treatment-Seeking Opioid Use Disorder Patients and Perceptions on Opioid-Related Overdose
    Connery, Hilary
    Mchugh, Kathryn
    Weiss, Roger
    Griffin, Margaret
    Taghian, Nadine
    AMERICAN JOURNAL ON ADDICTIONS, 2019, 28 (03): : 172 - 172
  • [5] Evaluation of a Medicaid Lock-in Program Increased Use of Opioid Use Disorder Treatment but No Impact on Opioid Overdose Risk
    Naumann, Rebecca B.
    Roberts, Andrew W.
    Marshall, Stephen W.
    Skinner, Asheley C.
    MEDICAL CARE, 2019, 57 (03) : 213 - 217
  • [6] Opioid overdose survivors: Medications for opioid use disorder and risk of repeat overdose in Medicaid patients
    Crystal, Stephen
    Nowels, Molly
    Samples, Hillary
    Olfson, Mark
    Williams, Arthur Robin
    Treitler, Peter
    DRUG AND ALCOHOL DEPENDENCE, 2022, 232
  • [7] Prior use of medications for opioid use disorder in ED patients with opioid overdose: prevalence, misuse and overdose severity
    Shastry, Siri
    Nobel, Ishak
    Allen, Lisa R.
    Richardson, Lynne D.
    Vidal, Kavey
    Manini, Alex F.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 51 : 114 - 118
  • [8] Overdose history is associated with postdetoxification treatment preference for persons with opioid use disorder
    Stein, Michael D.
    Flori, Jessica N.
    Risi, Megan M.
    Conti, Micah T.
    Anderson, Bradley J.
    Bailey, Genie L.
    SUBSTANCE ABUSE, 2017, 38 (04) : 389 - 393
  • [9] Behavioral pharmacology of methocinnamox: A potential new treatment for opioid overdose and opioid use disorder
    Maguire, David R.
    France, Charles P.
    JOURNAL OF THE EXPERIMENTAL ANALYSIS OF BEHAVIOR, 2023, 119 (02) : 392 - 406
  • [10] The development of opioid vaccines as a novel strategy for the treatment of opioid use disorder and overdose prevention
    Tuncturk, Mustafa
    Kushwaha, Shikha
    Heider, Robin M.
    Oesterle, Tyler
    Weinshilboum, Richard
    Ho, Ming-Fen
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 (02):